Physician

Thomas Allen Woltjer, D.O.

According to 2025 Medicare claims, Thomas Woltjer, D.O. (NPI: 1376989202) practices ophthalmology in the Wichita, KS market, with the plurality of this provider's patient population coming from Sedgwick, KS. This provider's primary affiliated billing organization is VITREO-RETINAL CONSULTANTS & SURGEONS PA (NPI: 1275557761; TIN: 48-0817150) and primary practice location at 67214-4837. Woltjer is affiliated with the Keystone ACO (ACO ID: A1552), participating under the MSSP model.

Woltjer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 438 traditional Medicare patients, billed 2,188 HCPCS/CPT codes, and received $112,500 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 295 prescription claims across 104 beneficiaries totaling $24,636 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 6 records totaling $578. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $131,082 to $112,500. In contrast, Part D prescription costs have risen steadily, from $1,845 to $24,636. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$460K$921K2017 Medicare payment: $131,082 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $573,323 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $699,705 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $920,529 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $831,214 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $96,012 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $123,121 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $112,500 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017210720$131,082
20188353,674$573,323
20198674,624$699,705
20204255,418$920,529
20215694,096$831,214
20223421,799$96,012
20233942,218$123,121
20244382,188$112,500

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$16K$32K2017 Drug cost: $1,845 (USD; Tot_Drug_Cst)2018 Drug cost: $19,132 (USD; Tot_Drug_Cst)2019 Drug cost: $17,180 (USD; Tot_Drug_Cst)2020 Drug cost: $24,051 (USD; Tot_Drug_Cst)2021 Drug cost: $32,392 (USD; Tot_Drug_Cst)2022 Drug cost: $21,919 (USD; Tot_Drug_Cst)2023 Drug cost: $26,641 (USD; Tot_Drug_Cst)2024 Drug cost: $24,636 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171119$1,845
201875171$19,132
201993191$17,180
2020167431$24,051
2021193512$32,392
2022116275$21,919
2023108322$26,641
2024104295$24,636

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more6363$117
67028Injection of drug into eye131363$69
92014Established patient complete exam of visual system261333$46
92134Imaging of retina378722$18
92250Photography of the retina5666$14

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium701,844$8,914
Prednisolone AcetatePrednisolone Acetate411,537$2,335
Flurbiprofen SodiumFlurbiprofen Sodium23920$970
Ketorolac TromethamineKetorolac Tromethamine30677$764
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat281,862$652

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$578Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Thomas Allen Woltjer, D.O.?

Tedicare shows public-source Medicare data for Thomas Allen Woltjer, D.O. (NPI 1376989202), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas Allen Woltjer, D.O. have ACO affiliation data?

Thomas Allen Woltjer, D.O. is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552).

What billing organization is linked to Thomas Allen Woltjer, D.O.?

Thomas Allen Woltjer, D.O. is linked to VITREO-RETINAL CONSULTANTS & SURGEONS PA (billing NPI 1275557761) in the available physician profile data.

Does Thomas Allen Woltjer, D.O. have Open Payments data?

Thomas Allen Woltjer, D.O. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.